Objective:The aim of this study was to screen for active components from medicinal plants of Uttarakhand that has potential for a therapeutic agent for AD by targetingthe secretase enzyme using in-silico approach. Methods: We used iGEMDOCK for in-silicodocking experiments to screen for active components from medicinal plant, can modulate secretase enzyme. Binding energies for active component from 112 medicinal plants were analyzed. Results: Our in-silicoanalysis suggests that Cardiofolioside, Azadirachtin, Berberine and Kutkin can best possible candidates for modulation of secretase enzyme and thus hold potential to help patients with AD. The results obtained clearly suggeststhat these active components from plants herbal have the ab...
Inhibition of Acetylcholinesterase (AChE) is still considered as the main therapeutic strategy again...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease with devastating outcomes to pa...
© 2020 John Wiley & Sons, Ltd. Alzheimer's disease (AD) is clinically characterized as memory defi...
Alzheimer's disease (AD) poses a significant global health challenge, necessitating novel therapeuti...
Objective: The aim of this study is to discover and identify the potential plant extracts that could...
BACKGROUND: Alzheimer's disease (AD) is a complex, multifactorial neurological disorder characterize...
Ethnopharmacological relevance : The aqueous decoction of Pterocarpus erinaceus has been traditional...
Since primitive times, herbs have been extensively used in conventional remedies for boosting cognit...
Alzheimer's Disease (AD), a neurological ailment, mostly affects the older population all around the...
Alzheimer’s disease (AD) is a neurodegenerative disease leading to irreversible neuronaldamage. Kanu...
Our current therapeutic drugs for Alzheimer's disease are predominantly derived from the alkaloid cl...
Urgent need to treat, prevent, delay the onset, slow the progression and reduce the symptoms of Alzh...
Background: Alzheimer’s disease is one of the most prevalent dementias in the elderly population wit...
Alzheimer’s disease (AD) is a brain disease characterized by gradual memory loss and cognitive impai...
Alzheimer’s disease is characterized by forgetfulness, disturbance in memory and loss of mental abil...
Inhibition of Acetylcholinesterase (AChE) is still considered as the main therapeutic strategy again...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease with devastating outcomes to pa...
© 2020 John Wiley & Sons, Ltd. Alzheimer's disease (AD) is clinically characterized as memory defi...
Alzheimer's disease (AD) poses a significant global health challenge, necessitating novel therapeuti...
Objective: The aim of this study is to discover and identify the potential plant extracts that could...
BACKGROUND: Alzheimer's disease (AD) is a complex, multifactorial neurological disorder characterize...
Ethnopharmacological relevance : The aqueous decoction of Pterocarpus erinaceus has been traditional...
Since primitive times, herbs have been extensively used in conventional remedies for boosting cognit...
Alzheimer's Disease (AD), a neurological ailment, mostly affects the older population all around the...
Alzheimer’s disease (AD) is a neurodegenerative disease leading to irreversible neuronaldamage. Kanu...
Our current therapeutic drugs for Alzheimer's disease are predominantly derived from the alkaloid cl...
Urgent need to treat, prevent, delay the onset, slow the progression and reduce the symptoms of Alzh...
Background: Alzheimer’s disease is one of the most prevalent dementias in the elderly population wit...
Alzheimer’s disease (AD) is a brain disease characterized by gradual memory loss and cognitive impai...
Alzheimer’s disease is characterized by forgetfulness, disturbance in memory and loss of mental abil...
Inhibition of Acetylcholinesterase (AChE) is still considered as the main therapeutic strategy again...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease with devastating outcomes to pa...
© 2020 John Wiley & Sons, Ltd. Alzheimer's disease (AD) is clinically characterized as memory defi...